2018 Publications
2018 Publications
January 1, 2018 through December 31, 2018
- Vaidya B, Sifat AE, Karamyan, VT, Abbruscato TJ The Neuroprotective Role of the Brain Opioid System in Stroke Injury. Drug Discovery Today, Mar 1. pii: S1359-6446(17)30460-9. doi: 10.1016/j.drudis.2018.02.011, 2018.
- Abbruscato TJ, Trippier PC. DARK Classics in Chemical Neuroscience: Methamphetamine.ACS
Chem Neurosci., Apr 6.
doi: 10.1021/acschemneuro.8b00123, 2018 - Villalba, H. Shah, K., Albekairi, T.H., Sifat A.E., Vaidya, B., Abbruscato TJ Potential role of myo-inositol to improve ischemic stroke outcome in diabetic mouse. Brain Research doi: 10.1016, 2018
- Sifat, A., Vaidya, V., Mohammad, K., Cucullo, L., Abbruscato, T.J. Nicotine & electronic cigarette (E-Cig) exposure decreases brain glucose utilization in ischemic stroke. J. Neurochem. doi:1111, 2018.
- Sifat, A. Vaidya, B., Villalba, H., Albekairi, T.H. and Abbruscato, T.J. Neurovascular unit transport responses to ischemia and common coexisting conditions: smoking and diabetes. American Journal Physiology-Cell Physiology (doi: 10.1152, 2018.
- Patel R, Hossain MA, German N, Al-Ahmad AJ. Gliotoxin penetrates and impairs the integrity
of the human blood-brain barrier in vitro. Mycotoxin research. 2018; PubMed [journal]
PMID: 30006720
Impact factor: 2.854 - Al-Ahmad AJ, Patel R, Palecek SP, Shusta EV. Hyaluronan impairs the barrier integrity
of brain microvascular endothelial cells through a CD44-dependent pathway. Journal
of cerebral blood flow and metabolism : official journal of the International Society
of Cerebral Blood Flow and Metabolism. 2018; 271678X18767748. PubMed [journal] PMID:
29589805
Impact factor: 4.929
- Alqahtani F, Chowdhury EA, Bhattacharya R, Noorani B, Mehvar R, Bickel U. Brain Uptake of [(13)C] and [(14)C]Sucrose Quantified by Microdialysis and Whole Tissue Analysis in Mice. Drug Metab Dispos. 2018;46(11):1514-8 Impact Factor 3.64
- Chowdhury EA, Alqahtani F, Bhattacharya R, Mehvar R, Bickel U. Simultaneous Uplc-Ms/Ms
Analysis of Two Stable Isotope Labeled Versions of Sucrose in Mouse Plasma and Brain
Samples as Markers of Blood-Brain Barrier Permeability and Brain Vascular Space. J
Chromatogr B Analyt Technol Biomed Life Sci. 2018;1073:19-26
Impact Factor 2.441
- Sivandzade F, Prasad S, Bhalerao A, Cucullo L:NRF2 and NF-қB interplay in Cerebrovascular
and Neurodegenerative disorders: Molecular Mechanisms and Possible Therapeutic Approaches.
Redox Biol 2018 (in press)
Impact factor: 7.126 - Sivandzade F, Cucullo L: In-vitro blood-brain barrier modeling: A review of modern
and fast-advancing technologies. J Cereb Blood Flow Metab 2018, 38(10):1667-1681.
Impact factor: 6.045 - Sifat AE, Vaidya B, Kaisar MA, Cucullo L, Abbruscato TJ: Nicotine and electronic cigarette
(E-Cig) exposure decreases brain glucose utilization in ischemic stroke. J Neurochem
2018, 147(2):204-221.
Impact factor: 4.609 - Sajja RK, Kaisar MA, Vijay V, Desai VG, Prasad S, Cucullo L: In Vitro Modulation of
Redox and Metabolism Interplay at the Brain Vascular Endothelium: Genomic and Proteomic
Profiles of Sulforaphane Activity. Sci Rep 2018, 8(1):12708.
Impact factor: 4.609 - Kaisar MA, Sivandzade F, Bhalerao A, Cucullo L: Conventional and electronic cigarettes
dysregulate the expression of iron transporters and detoxifying enzymes at the brain
vascular endothelium: In vivo evidence of a gender-specific cellular response to chronic
cigarette smoke exposure. Neurosci Lett 2018, 682:1-9.
Impact factor: 2.16 - Ashraf-Uz-Zaman M, Sajib MS, Cucullo L, Mikelis CM, German NA: Analogs of penfluridol
as chemotherapeutic agents with reduced central nervous system activity. Bioorg Med
Chem Lett 2018.
Impact factor: 2.442 - F. Sivandzade, A. Bhalerao, L. Cucullo. Analysis of the mitochondrial membrane potential
using the cationic JC-1 dye as a sensitive fluorescent probe. Bio-protocol (Accepted12-3-2018).
- Barthels D and Das H. Current advances in ischemic stroke research and therapies.
BBA-Molecular Basis of Disease. - In Press. 2018.
(IF: 5.108) - Das M, Laha D, Kanji S, Joseph M, Aggarwal R, Iwenofu H, Pompili VJ, Jain MK, and Das H. Induction of Krüppel-like factor 2 reduces K/BxN serum-induced arthritis. Journal of Cellular and Molecular Medicine- In Press. 2018. (IF: 4.3)
- Rolph DN, Deb M, Greene CJ, Das M, Joseph M, Aggarwal R, Leblebicioglu B and Das H. Ferutinin directs dental pulp-derived stem cells towards the osteogenic lineage by epigenetically regulating canonical Wnt signaling. BBA-Molecular Basis of Disease. - In Press. 2018. https://doi.org/10.1016/j.bbadis.2018.10.032. (IF: 5.108)
- Irons BK, Edwards KL, Chastain LM, Brown CD, Black RL, Seifert CF. Assessment of a
didactic ambulatory care pharmacy elective on student perceptions and subsequent performance
in an ambulatory care advanced pharmacy practice experience. Curr Pharm Teach Learn.
2018;10(9) - Accepted. *
H-index = 11 - Sigler MA, Congdon L, Edwards KL. An evidence-based review of statin use in patient
with nonalcoholic fatty liver disease. Clin Med Insights Gastroenterol. 2018; 11:1179552218787502.
doi: 10.1177/1179552218787502.
H-index = 8
- Ashraf-Uz-Zaman M, Sajib MS, Cucullo L, Mikelis CM, German NA. Analogs of penfluridol
as chemotherapeutic agents with reduced central nervous system activity. Bioorg Med
Chem Lett., 2018 Oct 24. pii: S0960-894X(18)30838-2. doi: 10.1016/j.bmcl.2018.10.036.
[Epub ahead of print] PubMed PMID: 30389290.
IF 2.41 - Nguyen T, Gamage TF, Decker AM, German N, Langston TL, Farquhar CE, Kenakin TP, Wiley
JL, Thomas BF, Zhang Y. Diarylureas containing 5-membered heterocycles as cb1 receptor
allosteric modulators: design, synthesis, and pharmacological evaluation. ACS Chem
Neurosci., 2018 Sep 20; PubMed PMID: 30188693.
IF 4.21- Dukat M, Jain A, German N, Ferrara-Pontoriero R, Huang Y, Ma Y, Schulte MK, Glennon
RA. Desformylflustrabromine (dFBr): a structure-activity study on its ability to potentiate
the action of acetylcholine at α4β2 nicotinic acetylcholine receptors. ACS Chem Neurosci.,
2018 Aug 2. [Epub ahead of print] PubMed PMID: 30028943.
IF 4.21
- Dukat M, Jain A, German N, Ferrara-Pontoriero R, Huang Y, Ma Y, Schulte MK, Glennon
RA. Desformylflustrabromine (dFBr): a structure-activity study on its ability to potentiate
the action of acetylcholine at α4β2 nicotinic acetylcholine receptors. ACS Chem Neurosci.,
2018 Aug 2. [Epub ahead of print] PubMed PMID: 30028943.
- Patel R, Hossain MA, German N, Al-Ahmad AJ. Gliotoxin penetrates and impairs the integrity
of the human blood-brain barrier in vitro. Mycotoxin Res. 2018 Jul 13., [Epub ahead
of print] PubMed PMID:3006720.
IF 2.854 - Gandhi K, Li C, German N, Skobowiat C, Carrillo M, Kallem RR, Larumbe E, Martinez
S, Chuecos M, Ventolini G, Nathanielsz P, Schlabritz-Loutsevitch N. Effect of maternal
high-fat diet on key components of the placental and hepatic endocannabinoid system.
Am J Physiol Endocrinol Metab, IF 2018 Apr 1;314(4):E322-E333.
IF 2.14 - Sajib S, Zahra FT, Lionakis MS, German NA, Mikelis CM. Mechanisms of angiogenesis
in microbe-regulated inflammatory and neoplastic conditions. Angiogenesis, 2018, Feb;21(1):1-14.
IF 4.35
- Hall RG 2nd, Yoo E, Faust A, Smith T, Goodman E, Mortensen EM, Raza J, Dehmami, Alvarez
CA. Impact of Piperacillin/Tazobactam on Nephrotoxicity in Patients with Gram-negative
Bacteremia. Int J Antimicrob Agents (Epub ahead of print).
Impact factor: 4.25 - Hall RG 2nd, Yoo E, Faust A, Smith T, Goodman E, Mortensen EM, Felder V, Alvarez C.
Impact of total body weight on acute kidney injury in patients with gram-negative
bacteremia. Expert Rev Clin Pharmacol 2018;11:651-4. PMID: 29718754
Impact factor: 2.76
- Hall RG 2nd, Yoo E, Faust A, Smith T, Goodman E, Mortensen EM, Raza J, Dehmami, Alvarez
CA. Impact of Piperacillin/Tazobactam on Nephrotoxicity in Patients with Gram-negative
Bacteremia. Int J Antimicrob Agents (Epub ahead of print).
Impact factor: 4.25 - Hall RG 2nd, Yoo E, Faust A, Smith T, Goodman E, Mortensen EM, Felder V, Alvarez C.
Impact of total body weight on acute kidney injury in patients with gram-negative
bacteremia. Expert Rev Clin Pharmacol 2018;11:651-4. PMID: 29718754
Impact factor: 2.76
- Kochanek DM, Ghouse SM, Karbowniczek MM*, Markiewski MM*. Complementing Cancer Metastasis.
Front Immunol. 2018 Jul 16;9:1629. doi: 10.3389/fimmu.2018.01629. eCollection 2018.
Review. PubMed PMID: 30061895; PubMed Central PMCID: PMC6054933.
Co-corresponding authors
Impact Factor of 6.429
- Blood pressure targets: How low should you go (and for whom)?
MacLaughlin EJ, Slaton JF, Young RB, DePalma SM. The Journal of family practice. 2018; 67(7):416;420;422;425. PubMed [journal] PMID: 29989610 - Hypertension guideline update: A new guideline for a new era. DePalma SM, Himmelfarb CD, MacLaughlin EJ, Taler SJ. JAAPA : official journal of the American Academy of Physician Assistants. 2018; 31(6):16-22. PubMed [journal] PMID: 29762202
- 2017 ACC/ AHA/ AAPA/ ABC/ ACPM/ AGS/ APhA/ ASH/ ASPC/ NMA/ PCNA Guideline for the Prevention,
Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of
the American College of Cardiology/American Heart Association Task Force on Clinical
Practice Guidelines. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison
Himmelfarb C, DePalma
SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC Jr, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA Sr, Williamson JD, Wright JT Jr. Hypertension (Dallas, Tex. : 1979). 2018; 71(6):e13-e115. PubMed [journal] PMID: 29133356 - 2017 ACC/ AHA/ AAPA/ ABC/ ACPM/ AGS/ APhA/ ASH/ ASPC/ NMA/ PCNA Guideline for the Prevention,
Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive
Summary: A Report of the American College of Cardiology/American Heart
Association Task Force on Clinical Practice Guidelines. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC Jr, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA Sr, Williamson JD, Wright JT Jr.
Hypertension (Dallas, Tex. : 1979). 2018; 71(6):1269-1324.
PubMed [journal] PMID: 29133354 - 2017 ACC/ AHA/ AAPA/ ABC/ ACPM/ AGS/ APhA/ ASH/ ASPC/ NMA/ PCNA Guideline for the Prevention,
Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of
the American College of Cardiology/American Heart Association Task Force on Clinical
Practice Guidelines. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison
Himmelfarb C, DePalma
SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC Jr, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA Sr, Williamson JD, Wright JT Jr. Journal of the American College of Cardiology. 2018; 71(19):e127-e248.
PubMed [journal] PMID: 29146535 - 2017 ACC/ AHA/ AAPA/ ABC/ ACPM/ AGS/ APhA/ ASH/ ASPC/ NMA/ PCNA Guideline for the Prevention,
Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive
Summary: A Report of the American College of Cardiology/American Heart
Association Task Force on Clinical Practice Guidelines. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC Jr, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA Sr, Williamson JD, Wright JT Jr.
Journal of the American College of Cardiology. 2018; 71(19):2199-2269. PubMed [journal] PMID: 29146533 - Pharmacist Intervention for Blood Pressure Control in Patients with Diabetes and/or
Chronic Kidney Disease. Anderegg MD, Gums TH, Uribe L, MacLaughlin EJ, Hoehns J, Bazaldua
OV, Ives TJ, Hahn DL,
Coffey CS, Carter BL. Pharmacotherapy. 2018; 38(3):309-318. NIHMSID: NIHMS934034 PubMed [journal] PMID: 29331037 PMCID: PMC5867244
- Kochanek DM, Ghouse SM, Karbowniczek MM, Markiewski MM. Complementing Cancer Metastasis.
Frontiers in immunology. 2018; 9:1629. PubMed [journal] PMID: 30061895, PMCID: PMC6054933,
Impact factor: 6.429 - Kolev M, Markiewski MM. Targeting complement-mediated immunoregulation for cancer
immunotherapy. Seminars in immunology. 2018; 37:85-97. NIHMSID: NIHMS943398 PubMed
[journal] PMID: 29454575, PMCID: PMC5984681,
Impact factor: 7.206
- Hossian, A.K.M.N., Sajib, M.S., Tullar, P.E., Mikelis, C.M., Mattheolabakis, G. Multipronged
activity of combinatorial miR-143 and miR-506 inhibits Lung Cancer cell cycle progression
and angiogenesis in vitro. Sci Rep. 2018 Jul 12;8(1):10495.
Impact factor: 4.122 - Punganuru, S.R., Madala, H.R., Mikelis, C.M., Dixit, A., Arutla, V., Srivenugopal,
K.S. Conception, synthesis, and characterization of a rofecoxib-combretastatin hybrid
drug with potent cyclooxygenase-2 (COX-2) inhibiting and microtubule disrupting activities
in colon cancer cell culture and xenograft models. Oncotarget 2018 May 25;9(40):26109-26129.
doi: 10.18632/oncotarget.25450.
Impact factor: 5.008 - Drummond, R.A., Zahra, F.T., Natarajan, M., Swamydas, M., Hsu, A.P., Wheat, L.J.,
Gavino, C., Vinh, D.C., Holland, S.H., Mikelis, C.M.*, Lionakis, M.S. GM-CSF Therapy
in Human CARD9 Deficiency. J Allergy Clin Immunol 2018 Jun 8. pii: S0091-6749(18)30846-7.
doi: 10.1016/j.jaci.2018.05.025. *Co-corresponding author
Impact factor: 13.258 - Collar, A.L., Swamydas, M., O’Hayre, M., Sajib, M.S., Hoffman, K.W., Singh, S.P.,
Mourad, A., Johnson, M.D., Ferre, E.M.N., Farber, J.M., Lim, J.K., Mikelis, C.M.,
Gutkind, J.S., Lionakis M.S. The homozygous CX3CR1-M280 mutation impairs human monocyte
survival. JCI Insight 2018 Feb 8;3(3). pii: 95417. doi: 10.1172/jci.insight.95417.
Impact factor: N/A yet - Sajib, M.S., Zahra, F.T., Lionakis, M.S., German, N., Mikelis C.M*. Mechanisms of
angiogenesis in microbe-regulated inflammatory and neoplastic conditions. Angiogenesis
2018 Feb;21(1):1-14. *Corresponding author
Impact factor: 5.253
- Hall, R.G.; W. Smith; W.C. Putnam and S. Pass, “An Evaluation of Tedizolid in the
Treatment of MRSA.” Expert Opinion on Pharmacotherapy, 2018, 19(13),1489-1494.
(IF = 3.9) - Gerber, D.E.; M.S. Beg; F. Fattah; A.E. Frankel; O. Fatunde; Y. Arriaga; J.E. Dowell;
A. Bisen; R.D. Leff; C.C. Meek; W.C. Putnam; Y. Dong; J. Bolluyt; V. Sarode; X. Luo;
Y. Xie; B. Schwartz and D. A. Boothman, “Phase 1 Study of ARQ 761, a β-Lapachone analog
that promotes NQO1-mediated programmed cancer cell necrosis.” British Journal of Cancer,
2018, 19(8), 928-936.
(IF = 5.9)
- Jung JH, Jung DB, Kim H, Lee H, Kang SE, Srivastava SK, Yun M and Kim SH (2018). ZNF746
promotes colorectal cancer progression via c-Myc stability mediated by GSK-3β and
Fbw7. Oncogene 2018 Apr 9. Doi: 10.1038/s41388-018-0225-0. [Epub ahead of print].
PMID: 29628506.
IF: 8.5 - Verma K, Gupta N, Zang T, Wangtrakluldee P, Srivastava SK, Penning TM and Trippier
PC (2018). AKR1C3 Inhibitor KV-37 Exhibits Antineoplastic Effects and Potentiates
Enzalutamide in Combination Therapy in Prostate Adenocarcinoma Cells. Molecular Cancer
Therapeutics, 2018 Jun 11. doi: 10.1158/1535-7163.MCT-17-1023. [Epub ahead of print].
PMID: 29891491.
IF: 5.7 - Kim CG, Lee H, Gupta N, Ramachandran S, Kaushik I, Srivastava S, Kim SH, Srivastava
SK (2018). Role of FOXO proteins in cancer metastasis. Seminars in Cancer Biology,
2018, 50: 142-151. PMID: 28774834.
IF: 10.19
- Rambaran KA, Seifert CF. Ciprofloxacin vs. Levofloxacin for Prophylaxis in Recipients of Hematopoietic Stem Cell Transplantation. Journal of Oncology Pharmacy Practice 2018;:1-7.
- Rambaran KA, Alzghari SK, Seifert CF. Evaluation of Factors which Influence Mortality in Gram-positive Bacteremia in Hemodialysis Patients. Cureus 2018;10(7):e2917.
- Irons BK, Edwards KL, Chastain LM, Black RL, Brown CD, Seifert CF. Assessment of a Didactic Ambulatory Care Pharmacy Elective on Student Perceptions and Subsequent Performance in an Ambulatory Care Advanced Pharmacy Practice Experience. Currents in Pharmacy Teaching and Learning 2018, .
- Pedigo J, Seifert CF. Rate of patients at elevated risk of opioid overdose visiting the emergency department. American Journal of Emergency Medicine 2018.
- Mostofa AGM, Srivenugopal KS. S-phase specific downregulation of human O6-methylguanine DNA methyltransferase and its serendipitous interactions with PCNA and p21cip1 proteins in glioma cells. Neoplasia 20 (4), 305-323, 2018. (IF 5.0)
- Madala HR, Punganuru SR, Ali-Osman F, Zhang R, Srivenugopal KS. Brain- and tumor-penetrating disulfiram nanoparticles: Sequence of cytotoxic events and efficacy in human glioma cell lines and intracranial xenografts. Oncotarget 9 (3), 3459-3482, 2018. (IF 5.0)
- Madala HR, Punganuru SR, Arutla V, Misra S, Thomas TJ, Srivenugopal KS. Beyond Brooding on Oncometabolic Havoc in IDH-Mutant Gliomas and AML: Current and Future Therapeutic Strategies. Cancers (Basel), 10 (2), pii: E49, 2018. (IF 5.32)
- Bobustuc G , Kassam A, Rovin R, Jeudy S, Smith J, Isley B, Singh M, Paranjpe A , Srivenugopal KS, MGMT Inhibition in ER-Positive Breast Cancer Leads to CDC2, TOP2A, AURKB, CDC20, KIF20A, cyclin A2, cyclin B2 and survivin inhibition and enhances response to temozolomide, Oncotarget 9(51), 29727-29742, 2018. (IF 5.0)
- Punganuru SR, Madal HR, Srivenugopal KS. Selective killing of breast cancer cells by the styryl lactone (R)-goniothalamin is mediated by glutathione conjugation, induction of oxidative stress and marked reactivation of the R175H mutant p53 protein, Carcinogenesis, 39, Jul 13. doi: 10.1093/carcin/bgy093, [Epub ahead of print] 2018. (IF 5.23)
- Punganuru SR, Arutla V, Madala HR, Srivenugopal KS. Design and characterization of a Rofecoxib-Combretastatin hybrid drug that exerts highly potent antimicrotubule, anti-angiogenesis properties and Cox-2 inhibition both in cell culture and xenograft models. Oncotarget, 9, 26109-26129, 2018. (IF 5.0)
- Punganuru SR, Madala HR, Arutla V, Srivenugopal KS. Cancer-specific biomarker hNQO1 activatable fluorescent probes for imaging cancer cells in vitro and in vivo. Cancers (Basel), 2018, In Press. (IF 5.32).
- Joelle Makoukji, Fadi Saadeh, Karl Albert Mansour, Sally El Sitt, Jamal Al Ali, Nihar
Kinarivala, Paul C. Trippier and Rose-Mary Boustany; Flupirtine derivatives as potential
treatment for the Neuronal Ceroid
Lipofuscinoses. Ann. Clin. Transl. Neurol. 2018, 5, 1089-1103.
IF: 4.649 - Kshitij Verma, Nehal Gupta, Tianzhu Zang, Beau Wangtrakluldee, Sanjay K. Srivastava,
Trevor M. Penning, and Paul C. Trippier; AKR1C3 inhibitor KV-37 exhibits antineoplastic
effects and potentiates
enzalutamide in combination therapy in prostate adenocarcinoma cells. Mol. Cancer Ther. 2018, 17, 1833-1845.
IF: 5.365 - Thomas J. Abbruscato and Paul C. Trippier; DARK Classics in Chemical Neuroscience: Methamphetamine.
ACS Chem. Neurosci. 2018, 9, 2373-2378.
IF: 4.211 - Paul C. Trippier; Molecule of the month: Relating organic chemistry principles to
drug action. J. Chem. Educ. 2018, 95, 1112-1117.
IF: 1.758
Published Book Chapters/ Editorials/ Commentaries
- M. A. Kaisar, V.V. Abhyankar, and L. Cucullo:” In vitro BBB models: working with static platforms and microfluidic systems” in “Blood-Brain Barrier – Methods and Protocols” by Springer Nature. Editor: Wolfgang Walz. (Accepted 07/27/2018) – Book chapter
- Anderson S, Jha P, and Das H. Molecular Mechanisms of Osteoclasts and Osteoblasts in Bone Remodeling and Pathogenesis. In Bone Regeneration: Concepts, Clinical Aspects and Future Directions. Nova Science Publishers Inc, editor Hiranmoy Das. Hauppauge, NY 11788 USA. Chapter 1, pages 1-24, 2018.
- Rolph DN and Das H. Nanofiber Expanded CD34+ Stem Cells for Osteoporosis Therapy. In Bone Regeneration: Concepts, Clinical Aspects and Future Directions. Nova Science Publishers Inc, editor Hiranmoy Das. Hauppauge, NY 11788 USA. Chapter 9, pages 281-324, 2018.
- Hossain, M.A, German, N.A. (2018) The role of hormones in bone health and disease. Nova Science Pub Inc. Bone Regeneration: concept, aspects and future directions.
- Irons B. Endocrine and Metabolic Disorders. In: Burke J, Cauffield J, El-Ibiary S, et al. eds. Updates in Therapeutics: The Pharmacotherapy Preparatory and Recertification Course, 2017 ed. Lenexa, KS: American College of Clinical Pharmacy, 2017:1-203-1-260.
- Trippier Paul C. Small Molecule inhibitors for acute myeloid leukemia: Where is the field heading? Future Med Chem. Aug 10, 2017.